Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis.
Saved in:
| Title: | Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis. |
|---|---|
| Authors: | Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Matsuda K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.; Japan Foundation for AIDS Prevention, Tokyo, Japan.; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan., Maeda K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan., Horii K; Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Okudera K; Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan., Oshiro Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Inamura N; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Nemoto T; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Takeuchi JS; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Li Y; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Tsuchiya K; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan., Gatanaga H; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan., Oka S; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan., Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Sugiyama H; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Aoyanagi N; Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan., Mitsuya H; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2023 Dec 20; Vol. 228 (12), pp. 1652-1661. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiad317 |
